Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (201-210 of 243) with videos related to

Pageof 25
Sort By:
European Urology Oncology|July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial CarcinomaRenate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Scientific Reports|August 4, 2016
Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney CarcinomasGabriel G Malouf, Eva Compérat, Hui Yao, et al.
European Urology|July 31, 2014
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic reviewHarman M Bruins, Erik Veskimae, Virginia Hernandez, et al.
The American Journal of Surgical Pathology|May 14, 2015
Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinomaKarl-Friedrich Deml, Hans-Ulrich Schildhaus, Eva Compérat, et al.
European Urology|August 18, 2024
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines UpdatePaolo Gontero, Alison Birtle, Otakar Capoun, et al.
European Urology Focus|May 31, 2021
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial CarcinomaSatoshi Katayama, Keiichiro Mori, Victor M Schuettfort, et al.
Biomarkers in Medicine|March 24, 2022
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancerVanessa Kuhl, Wyatt Clegg, Stephanie Meek, et al.
European Urology|April 8, 2022
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active CompoundIris E Ertl, Ursula Lemberger, Dafina Ilijazi, et al.
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
European Urology Oncology|January 22, 2022
Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42]Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Pageof 25

Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
European Urology Oncology|July 27, 2025
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial CarcinomaRenate Pichler, Nils C H van Creij, Laura S Mertens, et al.
Scientific Reports|August 4, 2016
Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney CarcinomasGabriel G Malouf, Eva Compérat, Hui Yao, et al.
European Urology|July 31, 2014
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic reviewHarman M Bruins, Erik Veskimae, Virginia Hernandez, et al.
The American Journal of Surgical Pathology|May 14, 2015
Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinomaKarl-Friedrich Deml, Hans-Ulrich Schildhaus, Eva Compérat, et al.
European Urology|August 18, 2024
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines UpdatePaolo Gontero, Alison Birtle, Otakar Capoun, et al.
European Urology Focus|May 31, 2021
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial CarcinomaSatoshi Katayama, Keiichiro Mori, Victor M Schuettfort, et al.
Biomarkers in Medicine|March 24, 2022
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancerVanessa Kuhl, Wyatt Clegg, Stephanie Meek, et al.
European Urology|April 8, 2022
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active CompoundIris E Ertl, Ursula Lemberger, Dafina Ilijazi, et al.
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
European Urology Oncology|January 22, 2022
Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42]Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Pageof 25